Literature DB >> 10617575

The TOR signaling cascade regulates gene expression in response to nutrients.

M E Cardenas1, N S Cutler, M C Lorenz, C J Di Como, J Heitman.   

Abstract

Rapamycin inhibits the TOR kinases, which regulate cell proliferation and mRNA translation and are conserved from yeast to man. The TOR kinases also regulate responses to nutrients, including sporulation, autophagy, mating, and ribosome biogenesis. We have analyzed gene expression in yeast cells exposed to rapamycin using arrays representing the whole yeast genome. TOR inhibition by rapamycin induces expression of nitrogen source utilization genes controlled by the Ure2 repressor and the transcriptional regulator Gln3, and globally represses ribosomal protein expression. gln3 mutations were found to confer rapamycin resistance, whereas ure2 mutations confer rapamycin hypersensitivity, even in cells expressing dominant rapamycin-resistant TOR mutants. We find that Ure2 is a phosphoprotein in vivo that is rapidly dephosphorylated in response to rapamycin or nitrogen limitation. In summary, our results reveal that the TOR cascade plays a prominent role in regulating transcription in response to nutrients in addition to its known roles in regulating translation, ribosome biogenesis, and amino acid permease stability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10617575      PMCID: PMC317202          DOI: 10.1101/gad.13.24.3271

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  61 in total

1.  Getting started with yeast.

Authors:  F Sherman
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Sequence and expression of GLN3, a positive nitrogen regulatory gene of Saccharomyces cerevisiae encoding a protein with a putative zinc finger DNA-binding domain.

Authors:  P L Minehart; B Magasanik
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

3.  The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione s-transferases.

Authors:  P W Coschigano; B Magasanik
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

4.  4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase.

Authors:  S R von Manteuffel; A C Gingras; X F Ming; N Sonenberg; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

5.  Purification and properties of glutamine synthetase from Saccharomyces cerevisiae.

Authors:  A P Mitchell; B Magasanik
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

Review 6.  TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals.

Authors:  N S Cutler; J Heitman; M E Cardenas
Journal:  Mol Cell Endocrinol       Date:  1999-09-10       Impact factor: 4.102

7.  Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.

Authors:  J Heitman; N R Movva; M N Hall
Journal:  Science       Date:  1991-08-23       Impact factor: 47.728

8.  Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases.

Authors:  C J Di Como; K T Arndt
Journal:  Genes Dev       Date:  1996-08-01       Impact factor: 11.361

9.  Regulation of glutamine-repressible gene products by the GLN3 function in Saccharomyces cerevisiae.

Authors:  A P Mitchell; B Magasanik
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

10.  Regulation of nitrogen assimilation in Saccharomyces cerevisiae: roles of the URE2 and GLN3 genes.

Authors:  W E Courchesne; B Magasanik
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

View more
  265 in total

1.  Saccharomyces cerevisiae GATA sequences function as TATA elements during nitrogen catabolite repression and when Gln3p is excluded from the nucleus by overproduction of Ure2p.

Authors:  K H Cox; R Rai; M Distler; J R Daugherty; J A Coffman; T G Cooper
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

Review 2.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Gln3p nuclear localization and interaction with Ure2p in Saccharomyces cerevisiae.

Authors:  A A Kulkarni; A T Abul-Hamd; R Rai; H El Berry; T G Cooper
Journal:  J Biol Chem       Date:  2001-06-14       Impact factor: 5.157

Review 4.  Autophagy in the eukaryotic cell.

Authors:  Fulvio Reggiori; Daniel J Klionsky
Journal:  Eukaryot Cell       Date:  2002-02

Review 5.  Gcn4p, a master regulator of gene expression, is controlled at multiple levels by diverse signals of starvation and stress.

Authors:  Alan G Hinnebusch; Krishnamurthy Natarajan
Journal:  Eukaryot Cell       Date:  2002-02

6.  Mds3 regulates morphogenesis in Candida albicans through the TOR pathway.

Authors:  Lucia F Zacchi; Jonatan Gomez-Raja; Dana A Davis
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

7.  Tryptophan permease gene TAT2 confers high-pressure growth in Saccharomyces cerevisiae.

Authors:  F Abe; K Horikoshi
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  Ammonia regulates VID30 expression and Vid30p function shifts nitrogen metabolism toward glutamate formation especially when Saccharomyces cerevisiae is grown in low concentrations of ammonia.

Authors:  G K van der Merwe; T G Cooper; H J van Vuuren
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

9.  Constitutive and nitrogen catabolite repression-sensitive production of Gat1 isoforms.

Authors:  Rajendra Rai; Jennifer J Tate; Isabelle Georis; Evelyne Dubois; Terrance G Cooper
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

10.  The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.

Authors:  Leslie Ripaud; Laurent Maillet; Christophe Cullin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.